Type I CRISPR-Cas targets endogenous genes and regulates virulence to evade mammalian host immunity.
about
The Discovery, Mechanisms, and Evolutionary Impact of Anti-CRISPRs.DNA Repair Interacts with Autophagy To Regulate Inflammatory Responses to Pulmonary Hyperoxia.CRISPR-Cas: Adapting to change.CRISPR control of virulence in Pseudomonas aeruginosa.Commentary: Type I CRISPR-Cas targets endogenous genes and regulates virulence to evade mammalian host immunityChromosomal Targeting by the Type III-A CRISPR-Cas System Can Reshape Genomes in Staphylococcus aureus.Cas9 enhances bacterial virulence by repressing the regR transcriptional regulator in Streptococcus agalactiae.Determining the Specificity of Cascade Binding, Interference, and Primed Adaptation In Vivo in the Escherichia coli Type I-E CRISPR-Cas System.CRISPR RNA-Dependent Binding and Cleavage of Endogenous RNAs by the Campylobacter jejuni Cas9.Transcriptomic Analysis of the Campylobacter jejuni Response to T4-Like Phage NCTC 12673 Infection.Lyn prevents aberrant inflammatory responses to infection in mammalian systems by repressing a SHIP-1-associated signaling clusterAnalysis Suggests Common Appearance of scaRNAs in Type II Systems and Their Association With Bacterial VirulenceTemperature, by Controlling Growth Rate, Regulates CRISPR-Cas Activity in Pseudomonas aeruginosa
P2860
Q38651010-C1DC139D-96B1-47CC-99F7-39F347123D74Q38716297-D8F9E829-2087-4319-9409-EC86A6F6B6DDQ39225316-DD3CA366-240B-4A04-96C3-8B9014449AF4Q40373202-262B7D0F-3E61-4B6A-8E48-B54E0E2B4BCFQ42319553-B98FCC1A-73FB-472E-A785-80F959A1CF41Q47142216-6D9B356C-2DCE-40E9-83F1-0A1E84AB34F8Q47921177-CB16E76C-90D1-44C4-A832-79CD3D9A21F3Q52318667-5F5466F1-D9FE-4A36-A4F7-0B9D6A8F1F47Q52430557-ECA578C1-BC4F-4735-BB7C-E5CFAE4C141FQ55657573-2D753A16-F655-4DAA-98B6-49D5735942D6Q57752587-0740D8FE-907A-4D85-BD02-DE5B7E720589Q58606297-B744F10F-C429-477F-89F2-FC7022ED1D7AQ59137641-344F8C5C-AC53-4F5F-ADB6-88DB37B7CA60
P2860
Type I CRISPR-Cas targets endogenous genes and regulates virulence to evade mammalian host immunity.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Type I CRISPR-Cas targets endo ...... evade mammalian host immunity.
@en
Type I CRISPR-Cas targets endo ...... evade mammalian host immunity.
@nl
type
label
Type I CRISPR-Cas targets endo ...... evade mammalian host immunity.
@en
Type I CRISPR-Cas targets endo ...... evade mammalian host immunity.
@nl
prefLabel
Type I CRISPR-Cas targets endo ...... evade mammalian host immunity.
@en
Type I CRISPR-Cas targets endo ...... evade mammalian host immunity.
@nl
P2093
P2860
P356
P1433
P1476
Type I CRISPR-Cas targets endo ...... evade mammalian host immunity.
@en
P2093
Guoping Li
Jianxin Jiang
Lizhu Fang
Rongpeng Li
Shirui Tan
Xuefeng Li
Yuquan Wei
P2860
P2888
P304
P356
10.1038/CR.2016.135
P577
2016-11-18T00:00:00Z